Animal diagnostics is essential to ensure better understanding of the cause of any ailment. Animal diagnostics consists of various instruments and consumables, which can assist in the diagnosis of diseases, whereas therapeutic agents are useful in the treatment of diseases via their mode of action. Animal diagnostics involves determination of the factors responsible for the onset of any disease and transmission of the same. This determination is done by diagnostic instruments and consumables. Therapeutic products used in the treatment of animals comprise of different drugs that help cure the disease through their mode of action.
The global animal therapeutics and diagnostics market was valued at
$23,793 million in 2015 and is projected to reach $36,226 million by 2022,
registering a CAGR of 6.1% during the forecast period, 2016 - 2022.
Download Report Sample @ https://www.alliedmarketresearch.com/request-sample/1949
Increase in number of animal population in the developing countries,
rise in demand for animal-based foods, and the rise in adoption of companion
animals is the major factor that fuels the growth of this market. The animal
therapeutics and diagnostics market has experienced moderate growth in the
recent years due to emerging diseases affecting livestock. The outbreak of
epidemics results in severe mass wipeouts of animals and is a growing concern
for the industries dependent on products obtained through farm animals.
Moreover, zoonotic diseases affecting animals pose a threat to the public
health making diagnosis and therapeutic products an important component in
disease management.
Animal therapeutics segment is anticipated to dominate the market with
maximum share, in 2015 in terms of revenue. Therapeutic products are used for
the treatment of various animal diseases. The treatment of diseases that affect
commercial animals such as poultry and cattle is even more important, as their
products in the form of milk and meat can be consumed by humans, which can lead
to foodborne diseases in case of infected animals.
Companion animals is expected to be the fastest growing segment
throughout the analysis period and accounts for almost one-thirds of the total
share of the market in 2015. This is due to the increase in adoption rate of
these animals, presence of strong bond between the owner and their companion
animals, and high disposable income of the owners.
Inquire before buying @ https://www.alliedmarketresearch.com/purchase-enquiry/1949
In 2015, North America displayed maximum contribution in the animal
diagnostics segment accounting for one-third of the total revenue generated
that year. North America also was the highest contributor in the growth of the
market for therapeutics in 2015. Asia-Pacific region observes fast paced growth
in both animal diagnostics and animal therapeutics market registering a CAGR of
7.8% and 6.6%, respectively. Rise in disposable income, increase in animal
healthcare expenditure, and increase in trend of adopting companion animals boost
the growth of the animal therapeutics and diagnostics market in the
Asia-Pacific region.
The Major Key Players Are:
Bayer AG, Eli Lilly and Company, Boehringer Ingelheim GmbH, Merck &
Co., Inc., Zoetis Inc., Ceva Sant Animale, Sanofi S.A., Nutreco N.V., and
Virbac S.A.
Key Findings of the Animal Diagnostics
and Therapeutics Market
- Consumables is projected to be the fastest growing segment during
the analysis period.
- Anti-parasitic drugs generated the highest revenue and is expected
to continue its dominance throughout the forecast period.
- North America dominated the global animal therapeutics and
diagnostics market and is projected to grow at a CAGR of 5.4%.
- Consumable animals segment occupied nearly one-third of the total
market in 2015.
- China is the fastest growing country in the Asia-Pacific region,
registering a CAGR of 7.8% from 2016 to 2022.
Access Full Report @ https://www.alliedmarketresearch.com/animal-therapeutics-diagnostics-market
About Us:
Allied Market Research (AMR) is a full-service
market research and business -consulting wing of Allied Analytics LLP based in
Portland, Oregon. Allied Market Research provides global enterprises as well as
medium and small businesses with unmatched quality of “Market Research Reports”
and “Business Intelligence Solutions.” AMR has a targeted view to provide
business insights and consulting to assist its clients to make strategic
business decisions and achieve sustainable growth in their respective market domain.
We are in professional corporate relations with
various companies and this helps us in digging out market data that helps us
generate accurate research data tables and confirms utmost accuracy in our
market forecasting. Each and every data presented in the reports published by
us is extracted through primary interviews with top officials from leading
companies of domain concerned. Our secondary data procurement methodology
includes deep online and offline research and discussion with knowledgeable professionals
and analysts in the industry.
